FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205280311> ?p ?o ?g. }

• W3205280311 abstract "Non-Vitamin K antagonist oral anticoagulants (NOACs) emerged as an alternative with comparable or superior efficacy and safety to vitamin K antagonists (VKAs) for stroke prevention in patients with non-valvular atrial fibrillation (AF).The aim of the current study was to investigate the patterns, predictors, timelines and temporal trends of shifting from VKAs to NOACs.In this retrospective observational study, the computerized database of a large healthcare provider in Israel, Maccabi Healthcare Services, was searched to identify patients with AF for whom either a VKA or NOAC was prescribed between 2012 and 2015. Time from diagnosis to therapy initiation and to shifting between therapies was evaluated.Out of 6987 eligible AF incident patients, 2338 (33.4%) initiated treatment with a VKA and 2221 (31.7%) with a NOAC. In addition, 5259 prevalent patients were analyzed. During the study period, NOAC prescriptions proportion among the newly diagnosed cases increased from 32 to 68.4% (p for trend < 0.001). The median time from diagnosis to first dispensing was greater in NOAC than VKA and decreased among patients treated with NOAC during the study period (2012: 1.9 and 0.3 months, 2015: 0.7 and 0.2 months, respectively). During follow-up, 3737 (49%) patients (54.3% and 47.1% of the incident and prevalent cases, respectively), shifted from a VKA to a NOAC, after a median of 22 months and 39 months in the incident and prevalent cases, respectively, decreasing throughout the study period. Female gender, younger age, southern district, higher CHADS2 and CHA2DS2-VASC score, non-smoking, and treatment with antiplatelets were associated with a greater likelihood for therapy shift. Shifting from a NOAC to a VKA decreased over time from 8 to 4.5% in 2012 to 0.5% and 0.7% in 2015 in the incident and prevalent groups, p < 0.001 respectively.Shifting from VKA to NOAC occurred in 50% of the cases, more frequently among incident cases, and younger patients with greater stroke risk. Shifting from a NOAC to a VKA was much less frequent, yet it occurred more often in incident cases and decreased over time. A socially and economically sensitive program to optimize the initiation of OAC therapy upon diagnosis is warranted." @default.
• W3205280311 created "2021-10-25" @default.
• W3205280311 creator A5003591633 @default.
• W3205280311 creator A5016672369 @default.
• W3205280311 creator A5021528284 @default.
• W3205280311 creator A5028079332 @default.
• W3205280311 creator A5037714249 @default.
• W3205280311 creator A5061426528 @default.
• W3205280311 creator A5061636317 @default.
• W3205280311 creator A5063446634 @default.
• W3205280311 creator A5068244845 @default.
• W3205280311 date "2021-10-13" @default.
• W3205280311 modified "2023-09-25" @default.
• W3205280311 title "Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends" @default.
• W3205280311 cites W1757837840 @default.
• W3205280311 cites W1963641435 @default.
• W3205280311 cites W1971505725 @default.
• W3205280311 cites W1980300036 @default.
• W3205280311 cites W2011936209 @default.
• W3205280311 cites W2023819634 @default.
• W3205280311 cites W2058611793 @default.
• W3205280311 cites W2090225839 @default.
• W3205280311 cites W2097854437 @default.
• W3205280311 cites W2102197227 @default.
• W3205280311 cites W2103053426 @default.
• W3205280311 cites W2114775432 @default.
• W3205280311 cites W2132505348 @default.
• W3205280311 cites W2133435868 @default.
• W3205280311 cites W2136489990 @default.
• W3205280311 cites W2145391133 @default.
• W3205280311 cites W2151074096 @default.
• W3205280311 cites W2170034816 @default.
• W3205280311 cites W2441025241 @default.
• W3205280311 cites W2509795914 @default.
• W3205280311 cites W2555550897 @default.
• W3205280311 cites W2604378539 @default.
• W3205280311 cites W2604738434 @default.
• W3205280311 cites W2616300024 @default.
• W3205280311 cites W2727872797 @default.
• W3205280311 cites W2738948630 @default.
• W3205280311 cites W2766383072 @default.
• W3205280311 cites W2804806966 @default.
• W3205280311 cites W2808897013 @default.
• W3205280311 cites W2887568033 @default.
• W3205280311 cites W2905067512 @default.
• W3205280311 cites W2957544571 @default.
• W3205280311 cites W3004050106 @default.
• W3205280311 cites W3082188176 @default.
• W3205280311 cites W3131543417 @default.
• W3205280311 cites W3161760182 @default.
• W3205280311 doi "https://doi.org/10.1186/s12872-021-02295-w" @default.
• W3205280311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8513259" @default.
• W3205280311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34645389" @default.
• W3205280311 hasPublicationYear "2021" @default.
• W3205280311 type Work @default.
• W3205280311 sameAs 3205280311 @default.
• W3205280311 citedByCount "3" @default.
• W3205280311 countsByYear W32052803112022 @default.
• W3205280311 countsByYear W32052803112023 @default.
• W3205280311 crossrefType "journal-article" @default.
• W3205280311 hasAuthorship W3205280311A5003591633 @default.
• W3205280311 hasAuthorship W3205280311A5016672369 @default.
• W3205280311 hasAuthorship W3205280311A5021528284 @default.
• W3205280311 hasAuthorship W3205280311A5028079332 @default.
• W3205280311 hasAuthorship W3205280311A5037714249 @default.
• W3205280311 hasAuthorship W3205280311A5061426528 @default.
• W3205280311 hasAuthorship W3205280311A5061636317 @default.
• W3205280311 hasAuthorship W3205280311A5063446634 @default.
• W3205280311 hasAuthorship W3205280311A5068244845 @default.
• W3205280311 hasBestOaLocation W32052803111 @default.
• W3205280311 hasConcept C120665830 @default.
• W3205280311 hasConcept C121332964 @default.
• W3205280311 hasConcept C126322002 @default.
• W3205280311 hasConcept C127413603 @default.
• W3205280311 hasConcept C167135981 @default.
• W3205280311 hasConcept C187212893 @default.
• W3205280311 hasConcept C23131810 @default.
• W3205280311 hasConcept C2426938 @default.
• W3205280311 hasConcept C2776301958 @default.
• W3205280311 hasConcept C2776704044 @default.
• W3205280311 hasConcept C2778810321 @default.
• W3205280311 hasConcept C2779161974 @default.
• W3205280311 hasConcept C2780645631 @default.
• W3205280311 hasConcept C2993590494 @default.
• W3205280311 hasConcept C61511704 @default.
• W3205280311 hasConcept C71924100 @default.
• W3205280311 hasConcept C78519656 @default.
• W3205280311 hasConcept C98274493 @default.
• W3205280311 hasConceptScore W3205280311C120665830 @default.
• W3205280311 hasConceptScore W3205280311C121332964 @default.
• W3205280311 hasConceptScore W3205280311C126322002 @default.
• W3205280311 hasConceptScore W3205280311C127413603 @default.
• W3205280311 hasConceptScore W3205280311C167135981 @default.
• W3205280311 hasConceptScore W3205280311C187212893 @default.
• W3205280311 hasConceptScore W3205280311C23131810 @default.
• W3205280311 hasConceptScore W3205280311C2426938 @default.
• W3205280311 hasConceptScore W3205280311C2776301958 @default.
• W3205280311 hasConceptScore W3205280311C2776704044 @default.
• W3205280311 hasConceptScore W3205280311C2778810321 @default.
• W3205280311 hasConceptScore W3205280311C2779161974 @default.

• next